Screening of Parkinson’s Differential MicroRNA Based on GEO Database and Its Clinical Verification

Table 5

KEGG enrichment terms.

ID	Description	value	Gene ID	Count
hsa05224	Breast cancer	0.013	HES1, WNT3, WNT5A, WNT16, GADD45A, SP1, FZD5, FGF18, NCOA1, FGF5, AKT1, APC	12
hsa05226	Gastric cancer	0.013	WNT3, FGFR2, WNT5A, WNT16, GADD45A, FZD5, FGF18, CCNE2, FGF5, AKT1, APC, HGF	12
hsa04550	Signaling pathways regulating pluripotency of stem cells	0.020	WNT3, FGFR2, WNT5A, KAT6A, INHBB, WNT16, FZD5, ACVR2B, AKT1, SMARCAD1, APC	11
hsa05217	Basal cell carcinoma	0.025	WNT3, WNT5A, BMP2, WNT16, GADD45A, FZD5, APC	7
hsa04668	TNF signaling pathway	0.028	MAP2K6, VEGFC, MAP2K4, CCL2, MMP14, ATF2, AKT1, CEBPB, BIRC3	9
hsa04010	MAPK signaling pathway	0.028	MAP2K6, VEGFC, FGFR2, MAP2K4, DUSP6, GADD45A, MAP3K2, RASA2, ATF2, FGF18, STK4, NTF3, TGFA, FGF5, AKT1, HGF	16
hsa05202	Transcriptional misregulation in cancer	0.028	AFF1, HOXA10, NR4A3, BCL11B, WNT16, DUSP6, GADD45A, SP1, ETV5, HOXA11, CEBPB, BIRC3	12
hsa04350	TGF-beta signaling pathway	0.031	PITX2, BMP2, INHBB, TFDP1, SP1, NEO1, ACVR2B, SMAD6	8